The War Against Cancer Pain: Are We Winning?

Home / Event

Date and Time

Tuesday, 4 August 2020
08:30 – 12:30

Location

E106 (RAI Amsterdam)

Fee

Additional Fee Required


Event/Session Summary

The War Against Cancer Pain: Are We Winning?

 
Half Day SIG Satellite Symposium

Hosted By: Cancer Pain SIG

  • Pain is the most frequent symptom in the presence of advanced cancer disease
  • One third of cancer patients may receive inadequate analgesia
  • Opioids may not be effective for all types of cancer-related pain<.li>
Pain in advanced disease may be related to the disease itself (eg, cancer), disease treatment (eg, surgery, or osteoporotic collapse from chronic steroid therapy in respiratory disease) or from co-morbid conditions and debility (eg, post-herpetic neuralgia, leg ulcers). Within each of these aetiologies, pain mechanisms may be nociceptive, neuropathic or most commonly a mix of both. Patients with advanced disease commonly experience psychological distress which impacts on pain perception, pain tolerance and response to analgesia. While opioids are often the mainstay of analgesic management, they are seldom effective for all pains and can have significant adverse effects in unskilled hands. Other drug and non-drug approaches should therefore be combined with opioids to improve pain outcomes.

 

Preliminary Agenda 

 08:30

Symposium Begins


 08:30-08:45

Opening Remarks
 

08:45-10:45

Overview of Cancer Pain Management
Stefan Wirz, MD, PhD (Germany)

Interventional Techniques in Cancer Pain 
Jordi Perez, MD, PhD (Canada)

Psychological Therapies in Cancer Pain Management

Tosin Adekeye (Nigeria)

 10:45-11:00

Morning Coffee Break


 11:00-12:15


The War Against Cancer Pain: Are we Winning?
Elizabeth Ogboli Nwasor, MD (Nigeria)

General Discussion
Moderator: Elizabeth Ogboli Nwasor, MD (Nigeria)

 12:15 Closing Remarks

 12:30

End of Symposium

 


Registration Rates

All rates listed in USD

 Registration Type

Rate (USD)

 IASP Member

$55

 Nonmember

$105

 IASP Trainee Member

$35

 IASP Member from a Developing
 Country*

$35


*The Developing Country rate is available to residents of countries with a gross national income of less than $15,000,
as defined by the World Bank.